CYP2C19 and diabetes mellitus: The findings of this exploratory cross-sectional register study clearly show that a large fraction of the Danish population and in particular persons with diabetes, especially the elderly, are exposed to drugs or drug combinations for which there exists dosing guidelines as well as FDA annotation related to PGx of CYP2D6, CYP2C19 and SLCO1B1.